Figure 4.
Percentage of patients with a vision of ≤0.1 in the different groups prior to and after treatment. MOG, myelin oligodendrocyte glycoprotein; AQP, aquaporin.
Percentage of patients with a vision of ≤0.1 in the different groups prior to and after treatment. MOG, myelin oligodendrocyte glycoprotein; AQP, aquaporin.